Interpace Diagnostics Group, Inc. 4
4 · Interpace Diagnostics Group, Inc. · Filed Mar 17, 2017
Insider Transaction Report
Form 4
SULLIVAN STEPHEN J
Director
Transactions
- Award
Stock Option (right to buy)
2017-03-15+13,000→ 13,000 totalExercise: $2.18Exp: 2027-03-15→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable over a one-year period, commencing on March 15, 2017, in twelve equal installments, on the 14th day of each calendar month, subject to the reporting person's continued service with the issuer.